Consistent with reports, ANRIL is associated with poor prognosis in cervical cancer, and in the cytoplasm, the ANRIL/miR-186 axis may promote carcinogenesis through the PI3K/Akt signaling pathway [23]. The gene discussed is CDKN2B-AS1; the disease is cervical cancer.